These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38006959)

  • 1. Post-tuberculosis lung disease and inflammatory role players: can we characterise the myriad inflammatory pathways involved to gain a better understanding?
    Malefane L; Maarman G
    Chem Biol Interact; 2024 Jan; 387():110817. PubMed ID: 38006959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic and imaging signatures in post tuberculosis lung disease.
    Singh S; Allwood BW; Chiyaka TL; Kleyhans L; Naidoo CC; Moodley S; Theron G; Segal LN
    Tuberculosis (Edinb); 2022 Sep; 136():102244. PubMed ID: 36007338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term management of people with post-tuberculosis lung disease.
    Seo W; Kim HW; Kim JS; Min J
    Korean J Intern Med; 2024 Jan; 39(1):7-24. PubMed ID: 38225822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden, clinical features, and outcomes of post-tuberculosis chronic obstructive lung diseases.
    Sehgal IS; Dhooria S; Muthu V; Salzer HJF; Agarwal R
    Curr Opin Pulm Med; 2024 Mar; 30(2):156-166. PubMed ID: 37902135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Post-tuberculosis lung disease: a neglected disease].
    Ma Y; Ye XP; Fu XY; Wu GH
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Oct; 45(10):955-959. PubMed ID: 36207951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-Tuberculosis Lung Disease: Clinical Review of an Under-Recognised Global Challenge.
    Allwood BW; Byrne A; Meghji J; Rachow A; van der Zalm MM; Schoch OD
    Respiration; 2021; 100(8):751-763. PubMed ID: 33401266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of disease severity on nitrite and cytokine production by peripheral blood mononuclear cells (PBMC) from patients with pulmonary tuberculosis (TB).
    Dlugovitzky D; Bay ML; Rateni L; Fiorenza G; Vietti L; Farroni MA; Bottasso OA
    Clin Exp Immunol; 2000 Dec; 122(3):343-9. PubMed ID: 11122239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and biomarkers for post-tuberculosis lung damage in a Chinese cohort of male smokers and non-smokers: protocol for a prospective observational study.
    Gai X; Cao W; Rao Y; Zeng L; Xu W; Wu H; Li G; Sun Y
    BMJ Open; 2023 Oct; 13(10):e065990. PubMed ID: 37813532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post tuberculosis lung disease and tuberculosis sequelae: A narrative review.
    Cupido G; Günther G
    Indian J Tuberc; 2024 Jan; 71(1):64-72. PubMed ID: 38296392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical standards for the assessment, management and rehabilitation of post-TB lung disease.
    Migliori GB; Marx FM; Ambrosino N; Zampogna E; Schaaf HS; van der Zalm MM; Allwood B; Byrne AL; Mortimer K; Wallis RS; Fox GJ; Leung CC; Chakaya JM; Seaworth B; Rachow A; Marais BJ; Furin J; Akkerman OW; Al Yaquobi F; Amaral AFS; Borisov S; Caminero JA; Carvalho ACC; Chesov D; Codecasa LR; Teixeira RC; Dalcolmo MP; Datta S; Dinh-Xuan AT; Duarte R; Evans CA; García-García JM; Günther G; Hoddinott G; Huddart S; Ivanova O; Laniado-Laborín R; Manga S; Manika K; Mariandyshev A; Mello FCQ; Mpagama SG; Muñoz-Torrico M; Nahid P; Ong CWM; Palmero DJ; Piubello A; Pontali E; Silva DR; Singla R; Spanevello A; Tiberi S; Udwadia ZF; Vitacca M; Centis R; D Ambrosio L; Sotgiu G; Lange C; Visca D
    Int J Tuberc Lung Dis; 2021 Oct; 25(10):797-813. PubMed ID: 34615577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Pulmonary Aspergillosis as a Considerable Complication in Post-Tuberculosis Lung Disease.
    Neuböck MJ; ; Günther G; Barac A; Davidsen JR; Laursen CB; Agarwal R; Sehgal IS; Lange C; Salzer HJF
    Semin Respir Crit Care Med; 2024 Feb; 45(1):102-113. PubMed ID: 38196060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for genetic susceptibility towards development of posttransplant lymphoproliferative disorder in solid organ recipients.
    Babel N; Vergopoulos A; Trappe RU; Oertel S; Hammer MH; Karaivanov S; Schneider N; Riess H; Papp-Vary M; Neuhaus R; Gondek LP; Volk HD; Reinke P
    Transplantation; 2007 Aug; 84(3):387-91. PubMed ID: 17700165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment.
    Sahiratmadja E; Alisjahbana B; de Boer T; Adnan I; Maya A; Danusantoso H; Nelwan RH; Marzuki S; van der Meer JW; van Crevel R; van de Vosse E; Ottenhoff TH
    Infect Immun; 2007 Feb; 75(2):820-9. PubMed ID: 17145950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro synthesis of interferon-gamma, interleukin-4, transforming growth factor-beta and interleukin-1 beta by peripheral blood mononuclear cells from tuberculosis patients: relationship with the severity of pulmonary involvement.
    Dlugovitzky D; Bay ML; Rateni L; Urízar L; Rondelli CF; Largacha C; Farroni MA; Molteni O; Bottasso OA
    Scand J Immunol; 1999 Feb; 49(2):210-7. PubMed ID: 10075027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Research advances in post-tuberculosis lung disease].
    Deng MH; Zhang SY; Wang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Oct; 45(10):1041-1045. PubMed ID: 36207960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the levels of some hemostatic and inflammatory markers between tuberculosis patients with and without malaria at pretreatment, intensive, and continuation phase treatment.
    Okeke CO; Amilo GI; Ifeanyichukwu MO; Okeke CM
    Int J Mycobacteriol; 2020; 9(4):373-379. PubMed ID: 33323652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients.
    Lee TC; Savoldo B; Barshes NR; Rooney CM; Heslop HE; Gee AP; Caldwell Y; Scott JD; Goss JA
    Clin Transplant; 2006; 20(3):389-93. PubMed ID: 16824159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-β, Interleukin-23 and interleukin-1β modulate TH22 response during active multidrug-resistant tuberculosis.
    Imperiale BR; Gamberale A; Yokobori N; García A; Bartoletti B; Aidar O; López B; Cruz V; González Montaner P; Palmero DJ; de la Barrera S
    Immunology; 2024 Jan; 171(1):45-59. PubMed ID: 37715690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination in post-tuberculosis lung disease management: A review of the evidence.
    Nasiri MJ; Silva DR; Rommasi F; Zahmatkesh MM; Tajabadi Z; Khelghati F; Sarmastzadeh T; Centis R; D'Ambrosio L; Bombarda S; Dalcolmo MP; Galvão T; de Queiroz Mello FC; Rabahi MF; Pontali E; Solovic I; Tadolini M; Marconi L; Tiberi S; van den Boom M; Sotgiu G; Migliori GB
    Pulmonology; 2023 Sep; ():. PubMed ID: 37679219
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.